YM 022 |
| カタログ番号GC11938 |
YM 022 は、強力で選択的な経口活性ガストリン/コレシストキニン (CCK)-B 受容体 (CCK-BR) 拮抗薬です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 145084-28-2
Sample solution is provided at 25 µL, 10mM.
評判の良い論文で引用されたGlpBio製品
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 145084-28-2 | SDF | |
| Chemical Name | (R)-1-(2-oxo-1-(2-oxo-2-(o-tolyl)ethyl)-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-(m-tolyl)urea | ||
| Canonical SMILES | O=C1N(CC(C2=CC=CC=C2C)=O)C3=CC=CC=C3C(C4=CC=CC=C4)=N[C@H]1NC(NC5=CC=CC(C)=C5)=O | ||
| Formula | C32H28N4O3 | M.Wt | 516.6 |
| 溶解度 | <51.66mg/ml in DMSO; <5.17mg/ml in ethanol | Storage | Store at RT |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.9357 mL | 9.6787 mL | 19.3573 mL |
| 5 mM | 0.3871 mL | 1.9357 mL | 3.8715 mL |
| 10 mM | 0.1936 mL | 0.9679 mL | 1.9357 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC35037 1,3-Dicaffeoylquinic acid
- GC12401 GW9508
- GC38206 WRG-28
- GC19784 Sulfatase from Helix pomatia
- GC39026 Isobergapten
- GC41168 15-cyclohexyl pentanor Prostaglandin F2α
- GC42715 Ac-VDVAD-CHO (trifluoroacetate salt)
- GC38018 NHPI-PEG4-C2-Pfp ester
- GC12070 Ascorbic acid
- GC39094 Thonningianin A
- GC16720 Calcifediol monohydrate
- GC60315 Quercetin 3,7-dimethyl ether
- GC45006 Tedizolid Phosphate
- GC38612 Licoflavone B
- GC10113 LY 231617
- GC44707 Prostaglandin D2 Ethanolamide
- GC39501 PF-04634817 succinate
レビュー
Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *